Weichman BM[au] - Search Results

Year	Number of Results
1977	1
1979	2
1980	2
1981	1
1982	5
1983	7
1984	5
1985	5
1986	2
1987	4
1988	3
1989	6
1991	6
1992	2
1993	4
1994	3
2015	1
2017	1
2018	1
2019	3
2020	1
2022	0

1

Rapamycin: a novel immunosuppressive macrolide.

Sehgal SN, Molnar-Kimber K, Ocain TD, Weichman BM. Sehgal SN, et al. Among authors: weichman bm. Med Res Rev. 1994 Jan;14(1):1-22. doi: 10.1002/med.2610140102. Med Res Rev. 1994. PMID: 8309312 Review. No abstract available.

2

OnabotulinumtoxinA for Simultaneous Treatment of Upper Facial Lines: Subject-Reported Satisfaction and Impact From a Phase 3 Study.

Rivkin AZ, Ogilvie P, Dayan S, Yoelin SG, Weichman BM, Garcia JK. Rivkin AZ, et al. Among authors: weichman bm. Dermatol Surg. 2020 Jan;46(1):50-60. doi: 10.1097/DSS.0000000000001883. Dermatol Surg. 2020. PMID: 30829771 Clinical Trial.

3

Safe, Effective Chin and Jaw Restoration With VYC-25L Hyaluronic Acid Injectable Gel.

Ogilvie P, Sattler G, Gaymans F, Belhaouari L, Weichman BM, Snow S, Chawla S, Abrams S, Schumacher A. Ogilvie P, et al. Among authors: weichman bm. Dermatol Surg. 2019 Oct;45(10):1294-1303. doi: 10.1097/DSS.0000000000001960. Dermatol Surg. 2019. PMID: 31135570 Clinical Trial.

4

Lip and Perioral Enhancement With Hyaluronic Acid Dermal Fillers in Individuals With Skin of Color.

Taylor SC, Downie JB, Shamban A, Few J, Weichman BM, Schumacher A, Gallagher CJ. Taylor SC, et al. Among authors: weichman bm. Dermatol Surg. 2019 Jul;45(7):959-967. doi: 10.1097/DSS.0000000000001842. Dermatol Surg. 2019. PMID: 30789512

5

OnabotulinumtoxinA for Treatment of Forehead and Glabellar Lines: Subject-Reported Satisfaction and Impact From a Phase 3 Double-Blind Study.

Ogilvie P, Rivkin AZ, Dayan S, Yoelin SG, Weichman BM, Garcia JK. Ogilvie P, et al. Among authors: weichman bm. Dermatol Surg. 2019 May;45(5):689-699. doi: 10.1097/DSS.0000000000001779. Dermatol Surg. 2019. PMID: 31034447 Clinical Trial.

6

Safety and Effectiveness of the Hyaluronic Acid Dermal Filler VYC-17.5L for Nasolabial Folds: Results of a Randomized, Controlled Study.

Monheit G, Beer K, Hardas B, Grimes PE, Weichman BM, Lin V, Murphy DK. Monheit G, et al. Among authors: weichman bm. Dermatol Surg. 2018 May;44(5):670-678. doi: 10.1097/DSS.0000000000001529. Dermatol Surg. 2018. PMID: 29701621 Free PMC article. Clinical Trial.

7

Safety and Effectiveness of VYC-15L, a Hyaluronic Acid Filler for Lip and Perioral Enhancement: One-Year Results From a Randomized, Controlled Study.

Geronemus RG, Bank DE, Hardas B, Shamban A, Weichman BM, Murphy DK. Geronemus RG, et al. Among authors: weichman bm. Dermatol Surg. 2017 Mar;43(3):396-404. doi: 10.1097/DSS.0000000000001035. Dermatol Surg. 2017. PMID: 28157728 Clinical Trial.

8

Pemedolac: a novel and long-acting non-narcotic analgesic.

Chau TT, Weichman BM. Chau TT, et al. Among authors: weichman bm. J Pharmacol Exp Ther. 1989 Mar;248(3):907-15. J Pharmacol Exp Ther. 1989. PMID: 2703977

9

Subject satisfaction with onabotulinumtoxinA treatment of glabellar and lateral canthal lines using a new patient-reported outcome measure.

Rivers JK, Bertucci V, McGillivray W, Muhn C, Rosen N, Solish N, Weichman BM, Wheeler S, Daniels SR, Gallagher CJ. Rivers JK, et al. Among authors: weichman bm. Dermatol Surg. 2015 Aug;41(8):950-9. doi: 10.1097/DSS.0000000000000424. Dermatol Surg. 2015. PMID: 26218728 Clinical Trial.

10

Estradiol-binding kinetics of the activated and nonactivated estrogen receptor.

Weichman BM, Notides AC. Weichman BM, et al. J Biol Chem. 1977 Dec 25;252(24):8856-62. J Biol Chem. 1977. PMID: 925028 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results